Clarivate (CLVT) Q2 2026: Fifth Straight EPS Beat but Revenue Misses
As seen on the 24/7 Wall St. homepage on July 29, 2026.
Clarivate notched a fifth consecutive EPS beat on disciplined cost management, though revenue missed as the information services company sheds its Life Sciences segment and races to swap transactional business for recurring subscriptions. The company reaffirmed full-year guidance and expects organic recurring revenue growth to accelerate by over 100 basis points in the second half as AI-native products like Web of Science Research Intelligence gain traction.
Continue ReadingShow less
Clarivate reported Q2 2026 adjusted EPS of $0.19, beating the $0.1812 consensus estimate by roughly 5% and extending the company's streak of EPS beats to five consecutive quarters. Revenue came in at $587.3 million, just a hair below the $589.8 million estimate — a miss of less than half a percent — as the business continues to shed lower-quality transactional sales in favor of more predictable subscription contracts, and works through the divestiture of its Life Sciences segment.
The earnings beat reflects disciplined cost management that has consistently allowed Clarivate to outperform on the bottom line even when the top line falls short. Looking across the last several quarters, EPS has beaten estimates every time, with the spread widening notably in Q4 2025 and Q1 2026 as restructuring efforts took hold.
Sponsored
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Management reaffirmed its full-year guidance and expects organic recurring revenue growth to accelerate by more than 100 basis points in the second half of the year. That confidence is tied in part to AI-native products such as Web of Science Research Intelligence, which the company is positioning as a growth driver as it completes its pivot toward a subscription-first model.
Mentioned: CLVT